NCT02233790View on ClinicalTrials.gov

Ticagrelor and Clopidogrel on Reperfusion in Patients With AMI

PHASE4UnknownINTERVENTIONAL
Enrollment

600

Participants

Timeline

Start Date

December 31, 2014

Primary Completion Date

September 30, 2016

Study Completion Date

December 31, 2016

Conditions
Myocardial InfarctionNo-Reflow Phenomenon
Interventions
DRUG

Ticagrelor

a loading dose of 180mg pre-PCI, and then 90 mg twice daily for 1 Month within the study. Thereafter, the patients will take clopidogrel if Ticagrelor is not available on the market.

DRUG

Clopidogrel

Clopidogrel 75 mg once daily after a loading dose of 300 mg pre-PCI.

Trial Locations (1)

110001

The First Hospital of China Medical University, Shenyang

Sponsors

Collaborators (1)

AstraZeneca
All Listed Sponsors
collaborator

AstraZeneca

INDUSTRY

lead

First Hospital of China Medical University

OTHER